Cullinan Therapeutics, Inc. CGEM Stock Forecast
AI-powered price prediction and analysis for Cullinan Therapeutics, Inc. ยท Updated Apr 01, 2026
AI 90-Day Forecast
HOLD
7 Days
30 Days
90 Days
AI Confidence: 59% Spearman Correlation
April 01, 2026
See CGEM's Exact Price Target
Create a free account to unlock AI predictions for 4,000+ stocks
Sign Up Free with Googleโ Free account ยท โ 30-day trial ยท โ Cancel anytime
Price Chart
Loading chart...
Key Statistics
Market Cap
$840M
P/E Ratio
-4.1x
P/B Ratio
2.06x
EPS
$-2.84
ROE
-17.5%
Net Margin
-0.4%
Revenue
$24M
Current Ratio
18.68x
About Cullinan Therapeutics, Inc.
Cullinan Therapeutics, Inc. (CGEM) operates in the Life Sciences sector, specifically in the Biological Products, (No Diagnostic Substances) industry. The company employs approximately 73 people.
We do not have any company description for Cullinan Therapeutics, Inc. at the moment.
Latest News
- Cullinan Therapeutics Shares Additional Preclinical B Cell Depletion Data for CLN-978, Supporting Clinical Development Across Multiple Autoimmune Diseases, at ACR Convergence 2025
- Cullinan Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results
- Cullinan Therapeutics flags 2026 as โdefining yearโ at Leerink, tees up key CLN-978/CLN-049 data
- Sign up free to read all 11 articles โ
Biological Products, (No Diagnostic Substances) Peers
| Company | Ticker | AI Signal | Market Cap | P/E |
|---|---|---|---|---|
| Acumen Pharmaceuticals, Inc. | ABOS | โโ% | $188M | -1.9x |
| Abpro Holdings, Inc. | ABP | โโ% | $310K | -x |
| Abpro Holdings, Inc. | ABPO | โโ% | $460K | -x |
| Arcellx, Inc. | ACLX | โโ% | $6.65B | -74.1x |
| Alpha Cognition Inc. | ACOG | โโ% | $135M | -x |
| Adaptimmune Therapeutics Plc | ADAP | โโ% | $77M | -13.2x |
| Adma Biologics, Inc. | ADMA | โโ% | $2.17B | 14.8x |
| Adaptive Biotechnologies Corp | ADPT | โโ% | $2.23B | -4.6x |
| Adverum Biotechnologies, Inc. | ADVM | โโ% | $95M | -1.8x |
| Agenus Inc | AGEN | โโ% | $120M | 1047.3x |
| Agentix Corp. | AGTX | โโ% | $2M | -x |
| Aim Immunotech Inc. | AIM | โโ% | $2M | -0.5x |
| Aim Immunotech Inc. | AIMI | โโ% | $1M | -x |
| Alector, Inc. | ALEC | โโ% | $284M | -1.2x |
| Aligos Therapeutics, Inc. | ALGS | โโ% | $49M | -19.2x |
| Allogene Therapeutics, Inc. | ALLO | โโ% | $593M | -1.4x |
| Alvotech | ALVO | โโ% | $1.13B | -x |
| Amgen Inc | AMGN | โโ% | $190.18B | 24.7x |
| Apogee Therapeutics, Inc. | APGE | โโ% | $5.77B | -20.5x |
| Aptose Biosciences Inc. | APTOF | โโ% | $4M | -x |
| Argenx Se | ARGX | โโ% | $46.03B | -x |
| Armata Pharmaceuticals, Inc. | ARMP | โโ% | $378M | -1.0x |
| Artiva Biotherapeutics, Inc. | ARTV | โโ% | $165M | -x |
| Leonabio, Inc. | ATHA | โโ% | $23M | -0.2x |
| Atara Biotherapeutics, Inc. | ATRA | โโ% | $42M | 1.3x |
| Atyr Pharma Inc | ATYR | โโ% | $84M | -3.6x |
| Aura Biosciences, Inc. | AURA | โโ% | $427M | -4.9x |
| Autolus Therapeutics Plc | AUTL | โโ% | $365M | -x |
| Anavex Life Sciences โฆ | AVXL | โโ% | $289M | -17.3x |
| Bioatla, Inc. | BCAB | โโ% | $11M | -1.1x |
| Biocardia, Inc. | BCDA | โโ% | $12M | -0.6x |
| Brainstorm Cell Therapeutics โฆ | BCLI | โโ% | $10M | -4.9x |
| Biocryst Pharmaceuticals Inc | BCRX | โโ% | $2.35B | 8.9x |
| Black Diamond Therapeutics, โฆ | BDTX | โโ% | $133M | 6.0x |
| Beam Therapeutics Inc. | BEAM | โโ% | $2.46B | -12.6x |
| Biogen Inc. | BIIB | โโ% | $26.98B | 20.9x |
| Biontech Se | BNTX | โโ% | $22.47B | -x |
| Cabaletta Bio, Inc. | CABA | โโ% | $269M | -1.6x |
| Candel Therapeutics, Inc. | CADL | โโ% | $365M | -4.6x |
| C4 Therapeutics, Inc. | CCCC | โโ% | $262M | -2.6x |
| Cidara Therapeutics, Inc. | CDTX | โโ% | $6.49B | -1.0x |
| Creative Medical Technology โฆ | CELZ | โโ% | $7M | -3.4x |
| Cero Therapeutics Holdings, โฆ | CERO | โโ% | $650K | -x |
| Cullinan Therapeutics, Inc. | CGEM | โโ% | $840M | -4.1x |
| Compugen Ltd | CGEN | โโ% | $208M | 2.9x |
| Cg Oncology, Inc. | CGON | โโ% | $5.39B | -x |
| Cognition Therapeutics Inc | CGTX | โโ% | $79M | -0.5x |
| Coherus Oncology, Inc. | CHRS | โโ% | $261M | 1.6x |
| Calidi Biotherapeutics, Inc. | CLDI | โโ% | $2M | -0.9x |
| Cellectis S.A. | CLLS | โโ% | $340M | -x |
| Compass Therapeutics, Inc. | CMPX | โโ% | $968M | -4.8x |
| Mosaic Immunoengineering Inc. | CPMV | โโ% | $5M | -x |
| Caribou Biosciences, Inc. | CRBU | โโ% | $142M | -1.5x |
| Cardiff Oncology, Inc. | CRDF | โโ% | $110M | -4.0x |
| Cardiol Therapeutics Inc. | CRDL | โโ% | $156M | -x |
| Curis Inc | CRIS | โโ% | $21M | -0.3x |
| Crispr Therapeutics Ag | CRSP | โโ% | $4.68B | -12.1x |
| Champions Oncology, Inc. | CSBR | โโ% | $82M | 32.9x |
| Cel Sci Corp | CVM | โโ% | $29M | -0.9x |
| Dbv Technologies S.A. | DBVT | โโ% | $1.14B | -3.3x |
| Dbv Technologies S.A. | DBVTF | โโ% | $10K | -x |
| Ginkgo Bioworks Holdings, โฆ | DNA | โโ% | $319M | -13.9x |
| Denali Therapeutics Inc. | DNLI | โโ% | $2.82B | -8.7x |
| Precision Biosciences Inc | DTIL | โโ% | $131M | -2.2x |
| Dyadic International Inc | DYAI | โโ% | $31M | -7.3x |
| Editas Medicine, Inc. | EDIT | โโ% | $218M | -0.8x |
| Elutia Inc. | ELUT | โโ% | $44M | 0.8x |
| Engene Holdings Inc. | ENGN | โโ% | $414M | 3.7x |
| Entera Bio Ltd. | ENTX | โโ% | $51M | 8.5x |
| Viskase Holdings, Inc. | ENZN | โโ% | $4M | -x |
| Estrella Immunopharma, Inc. | ESLA | โโ% | $42M | -3.1x |
| Evaxion A/S | EVAX | โโ% | $31M | -x |
| Exelixis, Inc. | EXEL | โโ% | $11.01B | 14.1x |
| Exozymes Inc. | EXOZ | โโ% | $61M | -x |
| Fate Therapeutics Inc | FATE | โโ% | $122M | -1.3x |
| 4d Molecular Therapeutics, โฆ | FDMT | โโ% | $438M | -3.0x |
| Fennec Pharmaceuticals Inc. | FENC | โโ% | $210M | 1758.3x |
| Finch Therapeutics Group, โฆ | FNCH | โโ% | $15M | -0.1x |
| Futuretech Ii Acquisition โฆ | FTII | โโ% | $52M | -x |
| Futuretech Ii Acquisition โฆ | FTIIU | โโ% | $14M | -x |
| Gilead Sciences, Inc. | GILD | โโ% | $169.20B | 19.9x |
| Monte Rosa Therapeutics, โฆ | GLUE | โโ% | $1.32B | 59.5x |
| Genenta Science S.P.A. | GNTA | โโ% | $16M | -x |
| Green Planet Bio โฆ | GPLB | โโ% | $340K | -x |
| Halozyme Therapeutics, Inc. | HALO | โโ% | $7.32B | 23.1x |
| Humacyte, Inc. | HUMA | โโ% | $128M | -3.3x |
| Immunitybio, Inc. | IBRX | โโ% | $6.74B | -3.6x |
| Inhibikase Therapeutics, Inc. | IKT | โโ% | $194M | -1.0x |
| Immunocore Holdings Plc | IMCR | โโ% | $1.48B | -x |
| Immatics N.V. | IMTX | โโ% | $1.25B | -x |
| Immunovant, Inc. | IMVT | โโ% | $4.85B | -14.5x |
| In8bio, Inc. | INAB | โโ% | $13M | -x |
| Inhibrx Biosciences, Inc. | INBX | โโ% | $873M | -6.8x |
| Mink Therapeutics, Inc. | INKT | โโ% | $45M | -1.5x |
| Inmune Bio, Inc. | INMB | โโ% | $30M | -2.5x |
| Intensity Therapeutics, Inc. | INTS | โโ% | $14M | -2.2x |
| Iovance Biotherapeutics, Inc. | IOVA | โโ% | $1.45B | -4.5x |
| Century Therapeutics, Inc. | IPSC | โโ% | $365M | -0.7x |
| Invivyd, Inc. | IVVD | โโ% | $367M | -0.4x |
| Jasper Therapeutics, Inc. | JSPR | โโ% | $25M | -3.2x |
| Kalaris Therapeutics, Inc. | KLRS | โโ% | $121M | -x |
| Klotho Neurosciences, Inc. | KLTO | โโ% | $56M | -x |
| Kodiak Sciences Inc. | KOD | โโ% | $2.35B | -2.5x |
| Krystal Biotech, Inc. | KRYS | โโ% | $7.21B | 35.2x |
| Kymera Therapeutics, Inc. | KYMR | โโ% | $6.46B | -17.8x |
| Kyverna Therapeutics, Inc. | KYTX | โโ% | $458M | -x |
| Ladrx Corp | LADX | โโ% | $20K | -x |
| Lineage Cell Therapeutics, โฆ | LCTX | โโ% | $360M | -4.7x |
| Lenz Therapeutics, Inc. | LENZ | โโ% | $357M | -6.7x |
| Liminatus Pharma, Inc. | LIMN | โโ% | $10M | -x |
| Lexeo Therapeutics, Inc. | LXEO | โโ% | $385M | -0.4x |
| Maze Therapeutics, Inc. | MAZE | โโ% | $1.43B | -x |
| Mesoblast Ltd | MESO | โโ% | $1.90B | -x |
| Meiragtx Holdings Plc | MGTX | โโ% | $596M | -3.4x |
| Metagenomi Therapeutics, Inc. | MGX | โโ% | $50M | -x |
| Molecular Partners Ag | MOLN | โโ% | $160M | -x |
| Moderna, Inc. | MRNA | โโ% | $20.02B | -3.2x |
| Neurocrine Biosciences Inc | NBIX | โโ% | $12.80B | 26.7x |
| Nkgen Biotech, Inc. | NKGN | โโ% | $2M | -0.1x |
| Neumora Therapeutics, Inc. | NMRA | โโ% | $399M | -3.9x |
| Novavax Inc | NVAX | โโ% | $1.51B | 3.4x |
| Ocugen, Inc. | OCGN | โโ% | $547M | -4.3x |
| Outlook Therapeutics, Inc. | OTLK | โโ% | $22M | -0.2x |
| Palisade Bio, Inc. | PALI | โโ% | $291M | -0.2x |
| Passage Bio, Inc. | PASG | โโ% | $22M | -0.6x |
| Vaxcyte, Inc. | PCVX | โโ% | $7.62B | -20.4x |
| Biomx Inc. | PHGE | โโ% | $8M | 1.5x |
| Pluri Inc. | PLUR | โโ% | $34M | -1.4x |
| Protalix Biotherapeutics, Inc. | PLX | โโ% | $173M | 41.2x |
| Pharmacyte Biotech, Inc. | PMCB | โโ% | $8M | 0.3x |
| Prime Medicine, Inc. | PRME | โโ% | $617M | -1.5x |
| Prokidney Corp. | PROK | โโ% | $526M | -x |
| Qiagen N.V. | QGEN | โโ% | $9.11B | -x |
| Quince Therapeutics, Inc. | QNCX | โโ% | $5M | -1.7x |
| Qrons Inc. | QRON | โโ% | $150K | -x |
| Replimune Group, Inc. | REPL | โโ% | $602M | -3.8x |
| Repligen Corp | RGEN | โโ% | $6.61B | 135.2x |
| Regenxbio Inc. | RGNX | โโ% | $418M | -1.8x |
| Relay Therapeutics, Inc. | RLAY | โโ% | $1.84B | -2.0x |
| Revolution Medicines, Inc. | RVMD | โโ% | $19.08B | -11.1x |
| Recursion Pharmaceuticals, Inc. | RXRX | โโ% | $1.58B | -4.7x |
| Sab Biotherapeutics, Inc. | SABS | โโ% | $273M | 20.6x |
| Sana Biotechnology, Inc. | SANA | โโ% | $740M | -2.1x |
| Scilex Holding Co | SCLX | โโ% | $47M | -0.4x |
| Scinai Immunotherapeutics Ltd. | SCNI | โโ% | $2M | -287.8x |
| Sangamo Therapeutics, Inc | SGMO | โโ% | $82M | -1.6x |
| Solid Biosciences Inc. | SLDB | โโ% | $715M | -0.9x |
| Silexion Therapeutics Corp | SLXN | โโ% | $4M | -x |
| Senti Biosciences, Inc. | SNTI | โโ% | $24M | -1.1x |
| Scholar Rock Holding โฆ | SRRK | โโ% | $5.22B | -18.5x |
| Surrozen, Inc./De | SRZN | โโ% | $343M | -0.5x |
| Sutro Biopharma, Inc. | STRO | โโ% | $356M | -1.0x |
| Protara Therapeutics, Inc. | TARA | โโ% | $278M | -2.1x |
| Tarsus Pharmaceuticals, Inc. | TARS | โโ% | $2.87B | -12.4x |
| Tc Biopharm (Holdings) โฆ | TCBPY | โโ% | $10K | -x |
| Tscan Therapeutics, Inc. | TCRX | โโ% | $57M | -4.6x |
| Bio-Techne Corp | TECH | โโ% | $8.20B | 101.1x |
| Tectonic Therapeutic, Inc. | TECX | โโ% | $587M | -8.9x |
| Instil Bio, Inc. | TIL | โโ% | $56M | -1.1x |
| Tenaya Therapeutics, Inc. | TNYA | โโ% | $159M | -2.5x |
| Tourmaline Bio, Inc. | TRML | โโ% | $1.23B | -3.5x |
| Taysha Gene Therapies, โฆ | TSHA | โโ% | $1.26B | -3.0x |
| Titan Pharmaceuticals Inc | TTNP | โโ% | $6M | -0.5x |
| Tevogen Bio Holdings โฆ | TVGN | โโ% | $17M | -x |
| Twist Bioscience Corp | TWST | โโ% | $2.85B | -12.6x |
| Voyager Acquisition Corp./Cayman โฆ | VACH | โโ% | $372M | 41.3x |
| Voyager Acquisition Corp./Cayman โฆ | VACHU | โโ% | $68M | 6.7x |
| Valneva Se | VALN | โโ% | $548M | -x |
| Vericel Corp | VCEL | โโ% | $1.61B | 97.7x |
| Vir Biotechnology, Inc. | VIR | โโ% | $1.47B | -2.0x |
| Vivosim Labs, Inc. | VIVS | โโ% | $4M | -x |
| Vor Biopharma Inc. | VOR | โโ% | $738M | -0.6x |
| Vaxart, Inc. | VXRT | โโ% | $146M | 8.9x |
| Voyager Therapeutics, Inc. | VYGR | โโ% | $238M | 570.6x |
| Windtree Therapeutics Inc โฆ | WINT | โโ% | $320K | -0.4x |
| X4 Pharmaceuticals, Inc | XFOR | โโ% | $375M | 6.4x |
| Zeo Scientifix, Inc. | ZEOX | โโ% | $17M | -x |
| Zivo Bioscience, Inc. | ZIVO | โโ% | $26M | -31.3x |
| Zura Bio Ltd | ZURA | โโ% | $565M | -x |
FAQ
-
Is Cullinan Therapeutics, Inc. a good stock to buy?
Our AI analyzes Cullinan Therapeutics, Inc. daily. Check the signal above for the latest recommendation. Always do your own research before investing.
-
How accurate are Cullinan Therapeutics, Inc. predictions?
Our AI achieves a 59% Spearman correlation for this stock, with 67%+ average accuracy across 4,000+ stocks analyzed daily.
-
How often are forecasts updated?
Cullinan Therapeutics, Inc. forecasts are updated daily using the latest market data and AI models.
Ready to invest smarter?
Join thousands of investors using AI-powered stock predictions
Sign Up Freeโ Free account ยท โ 4,000+ stocks ยท โ Daily updates
Looking for a deeper analysis of Cullinan Therapeutics, Inc.?
View full institutional-grade analysis on Intratio โAI predictions are based on historical patterns and should not be the sole basis for investment decisions. Past performance does not guarantee future results. Always do your own research.